HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dan Dong Selected Research

EP2 Subtype Prostaglandin E Receptors

12/2021Identification of ACOT13 and PTGER2 as novel candidate genes of autosomal dominant polycystic kidney disease through whole exome sequencing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dan Dong Research Topics

Disease

9Neoplasms (Cancer)
12/2021 - 04/2009
3Breast Neoplasms (Breast Cancer)
03/2022 - 06/2019
2Carcinoma (Carcinomatosis)
01/2022 - 10/2017
2Membranous Glomerulonephritis (Membranous Nephropathy)
05/2021 - 12/2019
2Renal Cell Carcinoma (Grawitz Tumor)
06/2019 - 03/2019
2Neoplasm Metastasis (Metastasis)
06/2019 - 03/2019
2Lung Neoplasms (Lung Cancer)
06/2019 - 03/2019
2Stomach Neoplasms (Stomach Cancer)
03/2019 - 01/2018
2Body Weight (Weight, Body)
11/2013 - 06/2011
1Insulin Resistance
06/2022
1Inflammation (Inflammations)
06/2022
1Obesity
06/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2022
1Autosomal Dominant Polycystic Kidney (ADPKD)
12/2021
1Vasculitis (Vasculitides)
05/2021
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
05/2021
1Pain (Aches)
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Necrosis
01/2021
1HIV Infections (HIV Infection)
01/2021
1Hyperoxia
01/2021
1Triple Negative Breast Neoplasms
12/2020
1Obstructive Lung Diseases (Obstructive Lung Disease)
01/2020
1Lung Diseases (Lung Disease)
01/2020
1Necrobiotic Disorders (Necrobiosis)
01/2020
1Carcinogenesis
01/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2019
1Ovarian Neoplasms (Ovarian Cancer)
06/2019
1Diabetic Nephropathies (Diabetic Nephropathy)
04/2019
1Glioma (Gliomas)
03/2019
1Colorectal Neoplasms (Colorectal Cancer)
03/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019
1Melanoma (Melanoma, Malignant)
01/2018
1Hepatocellular Carcinoma (Hepatoma)
01/2018
1Colonic Neoplasms (Colon Cancer)
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Esophageal Squamous Cell Carcinoma
01/2018
1Lymphatic Metastasis
10/2017
1Paralysis (Palsy)
04/2017
1Mycoses (Diseases, Fungus)
12/2015
1Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)
01/2014
1Ovarian Pregnancy
01/2014
1Fibrosis (Cirrhosis)
11/2013
1Acute Kidney Injury (Acute Renal Failure)
01/2013
1Pneumonia (Pneumonitis)
06/2005

Drug/Important Bio-Agent (IBA)

5Long Noncoding RNAIBA
06/2019 - 10/2017
36-methyladenineIBA
03/2022 - 01/2020
3Messenger RNA (mRNA)IBA
01/2022 - 01/2020
3Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2013
3Biomarkers (Surrogate Marker)IBA
06/2019 - 10/2017
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 - 12/2021
2Cisplatin (Platino)FDA LinkGeneric
03/2022 - 01/2013
2Biological ProductsIBA
01/2020 - 06/2019
2Glycoproteins (Glycoprotein)IBA
06/2011 - 04/2009
1Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
06/2022
1Carrier Proteins (Binding Protein)IBA
03/2022
1CarcinogensIBA
03/2022
1olaparibIBA
03/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2022
1Acyl Coenzyme A (Acyl CoA)IBA
12/2021
1AnionsIBA
12/2021
1EP2 Subtype Prostaglandin E ReceptorsIBA
12/2021
1Adenosine Monophosphate (AMP)IBA
12/2021
1DNA (Deoxyribonucleic Acid)IBA
12/2021
1RNA-Binding Proteins (RNA-Binding Protein)IBA
12/2021
1Pharmaceutical PreparationsIBA
12/2021
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2021
1EnzymesIBA
01/2021
1ImmunosorbentsIBA
01/2021
1InterleukinsIBA
01/2021
1LipopolysaccharidesIBA
01/2021
1VaccinesIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2020
1PNC-27IBA
01/2020
1Sulfur DioxideIBA
01/2020
1Peptides (Polypeptides)IBA
01/2020
1Cadherins (E-Cadherin)IBA
01/2020
1Phospholipase A2 ReceptorsIBA
12/2019
1RNA (Ribonucleic Acid)IBA
10/2019
1Spironolactone (Aldactone)FDA LinkGeneric
04/2019
1RNA IIBA
03/2019
1dihydromyricetinIBA
01/2019
1Antisense RNA (Anti-Sense RNA)IBA
01/2018
1Acetates (Acetic Acid Esters)FDA Link
04/2017
1Anti-Bacterial Agents (Antibiotics)IBA
12/2015
1Natamycin (Pimaricin)FDA Link
12/2015
1CreatinineIBA
11/2013
1Triglycerides (Triacylglycerol)IBA
11/2013
1GalactosidasesIBA
11/2013
1GlucocorticoidsIBA
06/2011
1corticosterone acetateIBA
06/2011
1Fetal Proteins (Fetoprotein)IBA
06/2011
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
04/2009

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2020
1Radiotherapy
10/2019
1Intrauterine Devices (Intrauterine Device)
01/2014
1Therapeutics
06/2005